Hexal AG, Germany
| Държава: | Германия |
| Кратка информация: | HEXAL AG - Who we are The pharmaceutical company Hexal develops, manufactures and markets generic and innovative modern pharmaceuticals. Founded in 1986, Hexal is one of the largest German pharmaceutical company. Image: Capsules - HEXAL Products So that health remains affordable HEXAL provides affordable and quality generic medicines on the basis of over 300 proven active substances. With its wide range of products and companies in all major therapeutic areas are represented. The focus is on cardiovascular drugs, pain therapeutics and gastrointestinal drugs. HEXAL Products Image: Staff of the Hexal-Pharma GmbH production Salutas HEXAL nationally - manufacturing and sales in Germany With approximately 4,300 employees and six offices in the Federal Republic - including four plants in eastern Germany - are firmly committed to HEXAL domestic location. The heart of HEXAL pharmaceuticals production is the work of Salutas Pharma GmbH in Magdeburg, one of the most modern pharmaceutical centers of Europe. HEXAL production Image: Laboratory Technician Even good things can be improved still HEXAL-quality generic drugs are priced - and far more than mere copies. They guarantee the security of proven active ingredients and simultaneously benefit from further developments, which make their use easier and better. Since HEXAL attaches great importance to the targeted improvement of products, its own development has always played an important role. HEXAL is a leader in the field of "Difficult-to-make" products such as multiparticulate sustained-release preparations, transdermal therapeutic systems, or implants. Pioneering role in Germany's Hexal and in biosimilars, the follow-up products biotechnologically produced drugs. In Oberhaching, near Munich, develops and manufactures HEXAL since 1999, the so-called biosimilar medicinal products. HEXAL innovative - Research and Development The development enjoys its own HEXAL always been a top priority - and it's paying off. HEXAL in Germany is a leader in the so-called "difficult-to-make" generics. Patient-friendly formulations and new dosages of proven active ingredients HEXAL Medicines are affordable quality drugs - far more than mere copies. They guarantee the safety of drugs of proven benefit and also by specific developments and improvements in detail. The galenic optimization simplifies the use of substances proven medications for the patient and expanded the therapeutic spectrum for the treating physician. Additional dosage strengths, easily and accurately scored tablets, convenient dosing, a pleasant taste and (wherever possible) the absence of color or preservatives are just some of the good reasons for the "drug of your trust." Proven drug in a new dosage form - effervescent tablets facilitate the use of medication Special sustained release formulations provide constant uniform drug delivery Multiparticulate sustained-release preparations Innovative and sustained-release depot with specific release profiles allow a controlled influx of the drug in the body decrease and the frequency of intake of the drug. Transdermal therapeutic systems (TTS) and implants Drug-containing patches - another focus of research HEXAL - ensure a constant drug delivery through the skin and avoid fluctuations in drug concentration in the blood. When drug-bearing implants in the body are also special. Which serve as drug depots for controlled release of hormone replacement and pain management. Implants can be injected into the subcutaneous fat tissue, give the drug free for several weeks and thereby to dissolve residue. With a capital development HEXAL 2007 brought the first depot leuprolide in the form of a solid implant in the German market. Drug patches and implants - innovative drug depots on and under the skin Biotechnological production at HEXAL Biotechnology - Cell research at the highest level Pioneering role in Germany's Hexal and in biosimilars, the follow-up products biotechnologically produced drugs. In Oberhaching (near Munich) develops and manufactures HEXAL since 1999 the so-called biosimilar medicinal products. The company's biotech sector has a broad spectrum of genetic engineering and bio-pharmaceutical methods. HEXAL 2007 brought the first self-developed and available in Germany biosimilar epoetin alfa on the market. |
| Сайт: | http://www.hexal.de/ |
